Table 3.
Correlations between expression levels of mRNA of ANO1 and clinical parameters.
| overall (n = 81) | ANO1 positive(n = 55) | ANO1 negative(n = 26) | p value | |||
|---|---|---|---|---|---|---|
| N | % | N | % | |||
| Age | ||||||
| ≤55 | 38 | 24 | 63 | 14 | 37 | |
| >55 | 43 | 31 | 73 | 12 | 27 | 0.47 |
| Gender | ||||||
| male | 40 | 28 | 70 | 12 | 30 | |
| female | 41 | 27 | 66 | 14 | 34 | 0.83 |
| Tumor location | ||||||
| Stomach | 49 | 35 | 71 | 14 | 29 | |
| Small intestine | 22 | 13 | 59 | 9 | 41 | |
| Duodenum | 6 | 4 | 66 | 2 | 34 | |
| Colorectum | 4 | 3 | 75 | 1 | 25 | 0.7 |
| Histopathological | ||||||
| Epithelioid | 38 | 29 | 76 | 9 | 34 | |
| Spindle | 30 | 18 | 60 | 12 | 40 | |
| Mixed | 13 | 8 | 61 | 5 | 39 | 0.3 |
| Tumor size | ||||||
| ≤5 cm | 29 | 14 | 48 | 15 | 52 | |
| 5–10 cm | 36 | 28 | 78 | 8 | 22 | *0.018 |
| >10 cm | 16 | 13 | 81 | 3 | 19 | |
ANO1 expression was significantly higher in the group with tumor size (>10 cm, positive rate, 81%) than group with tumor size (5–10 cm, positive rate, 78%) and group with tumor size (≤5 cm, positive rate, 48%). No significant correlation was found between ANO1 expression and other clinical parameters.
Values of *p < 0.05 were considered statistically significant.